Microsoft teams up with AstraZeneca on AI incubator

HONG KONG, CHINA - The logo of  Microsoft is seen in a smartphone. (Photo by Alvin Chan/SOPA Images/LightRocket via Getty Images)
HONG KONG, CHINA - The logo of Microsoft is seen in a smartphone. (Photo by Alvin Chan/SOPA Images/LightRocket via Getty Images)

Microsoft is teaming up with UK drugmaker AstraZeneca on creating a health-tech incubator in Paris aimed at bringing new solutions to the field’s most difficult problems.

Startups joining the AI Factory for Health will gain access to AstraZeneca’s clinical expertise and legal skills, along with its links to health-care establishments and data, the companies said in a statement. Microsoft will provide technological skills and the services of its Azure cloud network.

The collaboration builds on Microsoft’s AI Factory, which has already supported 27 startups in various fields. It also involves Inria, the French national research institute for the digital sciences, and venture capital investors Partech Partners and Serena, according to the statement.

Pharma companies are turning to AI, machine learning and advanced computing to speed the costly search for drugs and determine which approaches are most likely to yield successful products. AstraZeneca just announced a collaboration with Schrodinger to use that company’s technology for predicting molecular binding, a key part of drug activity.

ZAR/USD
17.05
(-0.92)
ZAR/GBP
21.89
(-0.49)
ZAR/EUR
19.91
(-0.19)
ZAR/AUD
11.98
(-0.48)
ZAR/JPY
0.16
(-0.18)
Gold
1861.07
(+0.04)
Silver
22.88
(+0.12)
Platinum
844.51
(+0.50)
Brent Crude
42.23
(-0.12)
Palladium
2207.00
(+0.59)
All Share
53587.11
(-1.22)
Top 40
49547.74
(-1.16)
Financial 15
9401.28
(-1.95)
Industrial 25
72949.70
(-1.72)
Resource 10
53453.42
(-0.10)
All JSE data delayed by at least 15 minutes morningstar logo
Company Snapshot
Voting Booth
Do you think it was a good idea for the government to approach the IMF for a $4.3 billion loan to fight Covid-19?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes. We need the money.
11% - 1368 votes
It depends on how the funds are used.
73% - 8870 votes
No. We should have gotten the loan elsewhere.
16% - 1959 votes
Vote